Canine Superpowers: The Future of Early Cancer Detection | Itamar Bitan - Co-Founder, Dognosis

Episode notes

Send us Fan Mail Dogs can detect explosives, narcotics, missing persons, and even disease. But what if their greatest superpower isn't finding things - it's sensing molecular changes inside the human body long before symptoms appear? Today we're exploring whether the canine nose may hold the key to the next generation of cancer diagnostics. Itamar Bitan is the Co-Founder of Dognosis ( ), a pioneering company working to unlock one of nature's most extraordinary sensing systems - the canine nose - and combine it with cutting-edge brain-computer interfaces and machine learning. Driven by a passion for both human health and working dogs, Itamar brings together an unusual blend of expertise spanning elite military operations, canine behavior, disease detection, and technology innovation. He spent nearly four years serving in Oketz, the Israeli Defense Forces' elite special operations K9 unit, where he worked as both a combat soldier and commander, developing deep expertise in canine training, scent detection, and high-pressure operational environments.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• Less about Models; More about ArchitecturePractical AI · on Artificial intelligence85 / 100
• Code Review Is a Taste Problem | David Poll ⁨@GitHub⁩Hangar DX Podcast · on Artificial intelligence81 / 100
• 321 | How to Build an AI App Without Coding: From Idea to App Store with Replit & Claude by Bryce Rattner KeithleyLeveraging AI · on Artificial intelligence80 / 100
• The Content Management System Landscape with Matt GarrepyRunAs Radio · on Artificial intelligence80 / 100
• Rapid Response: OpenAI’s Critterz blowback - Director Nik Kleverov on year zero for HollywoodPioneers of AI · on Artificial intelligence76 / 100
• #191 - Battling AI Fear: Storytelling, Technology, and Disruptive Change with Paul Roehrig, Chief Strategy and Marketing Officer at AscendionFinite By Clarity · on Artificial intelligence60 / 100

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• Reversing Cellular Age: The Scientist Who Helped Create iPS Cells Reveals What’s Next - Dr. Koji Tanabe, Ph.D. - Founder and CEO, I Peace Inc.
• Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-Colton
• The End of High Cholesterol? The First Oral PCSK9 Drug Could Change Heart Medicine Forever - Dr. Norman Lepor, MD - Founder and Director, National Heart Institute
• The Hidden Heart Risk: Amgen’s Dr. Paul Burton on the Future of Preventing Heart Attacks - Dr. Paul Burton, M.D., Ph.D., F.A.C.C., M.R.C.S., F.R.C.P. - Senior Vice President and Chief Medical Officer - Amgen